Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,5R,8R,11R,14R,17R,20R)-2-(4-aminobutyl)-5,8,11,14,17-pentakis(carboxymethyl)-20-(6-(4-(5-(4-carboxyphenyl)thiazol-2-ylamino)-4-oxobutanamido)hexanamido)-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazadocosane-1,22-dioic acid
ID: ALA4177303
Chembl Id: CHEMBL4177303
PubChem CID: 145972003
Max Phase: Preclinical
Molecular Formula: C50H65N11O25S
Molecular Weight: 1252.19
Molecule Type: Small molecule
Associated Items: